Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare is benefiting from strong performance in its ambulatory care segment, which saw a 10.6% growth in revenue and 6.1% growth in adjusted EBITDA in the first quarter of 2026, resulting in a strong EBITDA margin of 36.7%. The company's surgical business also saw positive growth trends, with a 5.3% increase in net patient service revenues and a 0.2% increase in same-facility admissions. As a result, the company's overall EBITDA of $1.162 billion beat expectations and showed strong expense management. Additionally, while the company experienced a decline in HIX volumes and revenues, management feels that it has appropriately reserved for this impact. The company also has plans in place to improve LOS and manage commercial payer mix, which should help offset the impact of HIX declines.

Tenet Healthcare is currently facing a number of challenges, including a significant reduction in HIX enrollment leading to decreased revenue and a decrease in HIX volumes negatively impacting their profitability compared to Medicaid and Medicare beneficiaries. Additionally, there is uncertainty surrounding healthcare reform policies, which could have a wide impact on the company's funding environment. While their recent performance has been solid, there are concerns about potential moderating utilization and the possible impact of an economic downturn on their elective caseloads.